General
Preferred name
Fidarestat
Synonyms
(S,S)-FIDARESTAT ()
SNK 860 ()
Fidarestat ()
Aldos ()
P&D ID
PD013820
CAS
15825-24-8
105300-43-4
136087-85-9
Tags
drug candidate
available
Drug indication
Diabetic complication
Drug Status
experimental
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Fidarestat (SNK 860) is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 ¦ÌM, and 1.8 ¦ÌM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat (SNK 860) has the potential to treat diabetic disease.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
Cayman Chemical Bioactives
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugMAP
MedChem Express Bioactive Compound Library
NPC Screening Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
279.07
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
1
Ring Count
3
Aromatic Ring Count
1
cLogP
-0.5
TPSA
110.52
Fraction CSP3
0.25
Chiral centers
2.0
Largest ring
6.0
QED
0.6
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Metabolic Enzyme/Protease
Target
Aldose Reductase
Source data
